Close Menu

NEW YORK – Sonic Healthcare USA said on Tuesday it has expanded its license for the ThyroSeq Genomic Classifier, signing a new 15-year exclusive agreement with the University of Pittsburgh Medical Center, the test's developer.

Under the expanded agreement, the test, which aids in the management of thyroid nodules of indeterminate cytology, will become available through all of Sonic's clinical labs and anatomic pathology practices in the US. Previously, the company has offered the test only through its CBLPath division.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.